Cargando…

Comparing serum lead level in drug abuse pregnant women with non-addicted pregnant mothers referring to Shiraz university hospitals in 2017-2018

INTRODUCTION: In recent decades, there are multiple reports of lead poisoning in drug abusers in Iran and other Middle East countries. The lead in the mother's blood can cause many dangerous, harmful effects on the mother and the fetus. Therefore, in this study, we evaluated the blood lead leve...

Descripción completa

Detalles Bibliográficos
Autores principales: Rezaie, Mehrdad, Abolhassanzadeh, Seyedeh Zarrin, Haghighinejad, Hourvash
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Wolters Kluwer - Medknow 2019
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6559079/
https://www.ncbi.nlm.nih.gov/pubmed/31198732
http://dx.doi.org/10.4103/jfmpc.jfmpc_36_19
_version_ 1783425763100327936
author Rezaie, Mehrdad
Abolhassanzadeh, Seyedeh Zarrin
Haghighinejad, Hourvash
author_facet Rezaie, Mehrdad
Abolhassanzadeh, Seyedeh Zarrin
Haghighinejad, Hourvash
author_sort Rezaie, Mehrdad
collection PubMed
description INTRODUCTION: In recent decades, there are multiple reports of lead poisoning in drug abusers in Iran and other Middle East countries. The lead in the mother's blood can cause many dangerous, harmful effects on the mother and the fetus. Therefore, in this study, we evaluated the blood lead level (BLL) in pregnant women who were an illegal drug user and compared it with pregnant women who did not use these agents. METHOD: A cross-sectional study was conducted among 60 pregnant women referred to Shiraz Hazrat Zinab and Hafez Hospitals. All pregnant women with a history of any drug abuse were sampled. Two pregnant women without any history of drug abuse were sampled for each pregnant mother with a history of drug abuse on the same day. To check BLL, 5 cc blood sample of all participants sent to a reference laboratory. BLLs have been assessed by atomic absorption spectrophotometry with GBC Avanta, and all reports were confirmed by a specific pathologist. The data were completed with maternal demographic information and infants’ anthropometric indices. Data analysis was performed using SPSS software version 24, and the significance was 0.05. RESULTS: There was a significant difference in BLL among pregnant women with and without drug abuse history (9.91 ± 26.2 and 2.95 ± 0.7, respectively) (P-value: 0.001). The prevalence of lead levels of more than 5 μg/dl in mothers with and without substance abuse was 20% and 7.5%, respectively. Anthropometric indices, Apgar score, and gestational age in the mothers with a history of drug abuse were significantly lower than the control group (a significant level less than 0.05). CONCLUSION: The level of lead in pregnant women taking illegal drugs is higher than that of the control group who do not have a history of illegal drug abuse. On the other hand, it is likely that increased serum levels of lead with fetal complications and maternal health threats childbirth and clinical outcomes during childbirth.
format Online
Article
Text
id pubmed-6559079
institution National Center for Biotechnology Information
language English
publishDate 2019
publisher Wolters Kluwer - Medknow
record_format MEDLINE/PubMed
spelling pubmed-65590792019-06-13 Comparing serum lead level in drug abuse pregnant women with non-addicted pregnant mothers referring to Shiraz university hospitals in 2017-2018 Rezaie, Mehrdad Abolhassanzadeh, Seyedeh Zarrin Haghighinejad, Hourvash J Family Med Prim Care Original Article INTRODUCTION: In recent decades, there are multiple reports of lead poisoning in drug abusers in Iran and other Middle East countries. The lead in the mother's blood can cause many dangerous, harmful effects on the mother and the fetus. Therefore, in this study, we evaluated the blood lead level (BLL) in pregnant women who were an illegal drug user and compared it with pregnant women who did not use these agents. METHOD: A cross-sectional study was conducted among 60 pregnant women referred to Shiraz Hazrat Zinab and Hafez Hospitals. All pregnant women with a history of any drug abuse were sampled. Two pregnant women without any history of drug abuse were sampled for each pregnant mother with a history of drug abuse on the same day. To check BLL, 5 cc blood sample of all participants sent to a reference laboratory. BLLs have been assessed by atomic absorption spectrophotometry with GBC Avanta, and all reports were confirmed by a specific pathologist. The data were completed with maternal demographic information and infants’ anthropometric indices. Data analysis was performed using SPSS software version 24, and the significance was 0.05. RESULTS: There was a significant difference in BLL among pregnant women with and without drug abuse history (9.91 ± 26.2 and 2.95 ± 0.7, respectively) (P-value: 0.001). The prevalence of lead levels of more than 5 μg/dl in mothers with and without substance abuse was 20% and 7.5%, respectively. Anthropometric indices, Apgar score, and gestational age in the mothers with a history of drug abuse were significantly lower than the control group (a significant level less than 0.05). CONCLUSION: The level of lead in pregnant women taking illegal drugs is higher than that of the control group who do not have a history of illegal drug abuse. On the other hand, it is likely that increased serum levels of lead with fetal complications and maternal health threats childbirth and clinical outcomes during childbirth. Wolters Kluwer - Medknow 2019-05 /pmc/articles/PMC6559079/ /pubmed/31198732 http://dx.doi.org/10.4103/jfmpc.jfmpc_36_19 Text en Copyright: © 2019 Journal of Family Medicine and Primary Care http://creativecommons.org/licenses/by-nc-sa/4.0 This is an open access journal, and articles are distributed under the terms of the Creative Commons Attribution-NonCommercial-ShareAlike 4.0 License, which allows others to remix, tweak, and build upon the work non-commercially, as long as appropriate credit is given and the new creations are licensed under the identical terms.
spellingShingle Original Article
Rezaie, Mehrdad
Abolhassanzadeh, Seyedeh Zarrin
Haghighinejad, Hourvash
Comparing serum lead level in drug abuse pregnant women with non-addicted pregnant mothers referring to Shiraz university hospitals in 2017-2018
title Comparing serum lead level in drug abuse pregnant women with non-addicted pregnant mothers referring to Shiraz university hospitals in 2017-2018
title_full Comparing serum lead level in drug abuse pregnant women with non-addicted pregnant mothers referring to Shiraz university hospitals in 2017-2018
title_fullStr Comparing serum lead level in drug abuse pregnant women with non-addicted pregnant mothers referring to Shiraz university hospitals in 2017-2018
title_full_unstemmed Comparing serum lead level in drug abuse pregnant women with non-addicted pregnant mothers referring to Shiraz university hospitals in 2017-2018
title_short Comparing serum lead level in drug abuse pregnant women with non-addicted pregnant mothers referring to Shiraz university hospitals in 2017-2018
title_sort comparing serum lead level in drug abuse pregnant women with non-addicted pregnant mothers referring to shiraz university hospitals in 2017-2018
topic Original Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6559079/
https://www.ncbi.nlm.nih.gov/pubmed/31198732
http://dx.doi.org/10.4103/jfmpc.jfmpc_36_19
work_keys_str_mv AT rezaiemehrdad comparingserumleadlevelindrugabusepregnantwomenwithnonaddictedpregnantmothersreferringtoshirazuniversityhospitalsin20172018
AT abolhassanzadehseyedehzarrin comparingserumleadlevelindrugabusepregnantwomenwithnonaddictedpregnantmothersreferringtoshirazuniversityhospitalsin20172018
AT haghighinejadhourvash comparingserumleadlevelindrugabusepregnantwomenwithnonaddictedpregnantmothersreferringtoshirazuniversityhospitalsin20172018